Valid Nutrition

ilins.org

Valid Nutrition

Valid Nutrition’s LNS research

programme

Valid Nutrition

Victor Owino


Valid Nutrition

• Registered as a charity in Ireland

• Run as a commercial food business with focus on

managing costs, efficiency and good corporate governance

• No shareholders and all profits must be re-invested

• Local manufacture using local crops in countries affected

by malnutrition


Valid Nutrition

• Economic benefits go back to local industry

• Link nutrition with food security via providing markets

for a range of local crops

• Encourages diversity

• Greatly increases the cost efficiency of aid


• Cheap

Novel RUF Principles

• Local or regional production

• Minimize quantity of milk

• Locally available crops

• Palatable

• Ingredients that are part of usual menus

• Effective

• Outcomes comparable to that of the standard

product


Four RUFs developed since 2008

• Maize -Soya-Sorghum RUF with a small amount of milk

powder for use as a complementary food (RUCF)

among infants and young children 6-24 months old

• Maize-Soya-Sorghum RUF with a small amount of milk

powder for use as supplementary food (RUSF) among

children 6-59 months old

• Maize -Soya-Sorghum RUTF with no milk powder for

treatment of severely acutely malnourished children 6-59

months old

• Maize -Soya-Sorghum RUTF-HIV with no milk powder

for treatment of malnutrition among HIV-infected adults


Nutritional value

Type of

RUF

Energy

(Kcal/10

0g)

Energy as

Protein

(%/100

kcal)

Energy as

Fat

(%/100

kcal)

RUCF 508 6 55 3

RUSF 508 6 55 3

RUTF 521 10 60 3

RUTF-HIV 521 10 60 3

Reference

(UN Joint

Statement

2007)

520-550 10-12 45-60

Mineral-

Vitamin

premix

(g/100g)


Maize-Soya-Sorghum RUF


Acceptability tests

Type of

RUF

RUCF

Where Design Subjects Key Results Collaborato

rs

Lwiro,

South Kivu,

Dem Rep

Congo

Cross over

design (2

weeks RUCF, 1

wk washout, 2

weeks CSB)

35 Infants

aged 9-11

months of

age

Provisional

results show

high

acceptance

by mothers

and infants

CEMUBAC

RUTF

2 primary

schools in

Lusaka,

Zambia

Cross over

design (2 wks

RUTF, 1 1 wk

washout, 2

weeks

Plumpynut®)

47 children

aged 4-11

years old

Tendency

towards

more

preference

for RUTF

over

Plumpynut

LUDHMT


Acceptability tests

Type of

RUF

RUSF

Where Design Subjects Key Results Collaborator

s

MCH, Kilifi

District

Hospital

Kenya

RUSF given as

single treatment

with no

comparison

25 children

aged 6

months – 5

years of age

Accepted by

both mothers

and children

KEMRI-

Wellcome

Trust, Kilifi

RUTF-HIV

Homa Bay

Kenya

Cross over

design (2 wks

RUTF-HIV, 1

wk washout, 2

weeks

Plumpynut®

38 adults

(BMI

18-22), HIV

positive and

under ART

treatment

No major

differences in

preference

between

RUTF-HIV

and

Plumpynut

with both

positively

rated

KEMRI-

CPHR, MSF

France,

Institute of

Child Health

London


Acceptability Criteria

• CRITERIA 1: “Consumption of a quantity of

energy not less than 75% of the energy intake

(kcal/kg/day) from the control food”

• CRITERIA 2: “Frequency of ill-effects

associated with the food requiring withdrawal

from the trial


Effectiveness trials- RUSF

• Objective: To determine whether an outpatient-based strategy of

short-term supplementary feeding for moderately malnourished

children with acute infections achieves greater improvement in

anthropometric measurements of wasting than usual diet

• Where: Kilifi, Kenya

• 6 months to 5 years old children with MUAC


Effectiveness trials- RUCF

• Objective: To assess the efficacy of a 6-month supplementation with

the RUCF compared to Cerelac/CSB in preventing the occurrence

of growth faltering (stunting) during the first 2 years of life

• Where: Lwiro, Democratic Republic of Congo

• 6 -12 months old normal infants and young children

• Primary outcome: Stunting at 12 and 24 months of age


Effectiveness trials- RUTF

• Objectives: To estimate the effectiveness of a SMS-RUTF compared

to P-RUTF in treating SAM in severely acutely malnourished

children under-five years of age in Lusaka, Zambia.

• To estimate and compare the costs and cost-effectiveness of SMS-

RUTF and P-RUTF in treating SAM in children under-five years of

age in Lusaka, Zambia.

• Where: Lusaka, Zambia

• 6 -59 months old suffering from SAM

• Primary outcomes: recovery rate and cost effectiveness analysis


Effectiveness trials- RUTF-HIV

• Objectives: To compare the clinical and nutritional efficacy of a new

formulation, RUTF-HIV, against the currently used, highmilk/peanut-based,

product, Plumpynut®, in the treatment of HIV

associated secondary undernutrition.

• Where: Homa Bay, Kenya

• HIV+ adults, malnourished, starting standard ART regimes (BMI


Where are we?

• Acceptability completed for the four RUFs

• Next steps

• adjustment of the ingredients mix

• Adjustment of mineral vitamin complex

• Efficacy/effectiveness trials

More magazines by this user
Similar magazines